{"nct_id":"NCT06483334","title":"A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2024-07-17","start_date_type":"ACTUAL","primary_completion_date":"2028-07-28","primary_completion_date_type":"ESTIMATED","completion_date":"2028-07-28","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["MRK"]}